Here's Why Shares in Theravance Biopharma Exploded Today

Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate update.The pharmaceutical company is making good progress on its plans, specifically to develop sales of its once-daily nebulized (a drug delivery device that administers mist into lungs) long-acting muscarinic agent (LAMA), Yupelri (revefenacin), and generate earnings and cash flow from it, while advancing another key drug through phase 3.The latter is ampreloxetine, described by the company as "an investigational, once-daily, selective norepinephrine reuptake inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy."Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool